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Project Description
• Leverage an existing longitudinal cohort of midlife 
adults (AHAB) with two waves of data collected 10-16 
years apart. 
• Establish whether and to what degree (1) cognitive 
function and (2) epigenetic age change over the length 
of the 10-16 year follow-up, and (3) provisionally test in 
a subset of adults whether changes in epigenetic age 
are associated with changes in cognitive function over 
the follow-up interval. 
Potential Impact
• Cognitive decline and dementia convey 
substantial health and financial costs, and 
individuals and their families place high value 
on maintaining cognitive functions as they 
age. 
• Establishing epigenetic age as a biomarker of 
cognitive function in midlife can uncover pre-
clinical markers that may identify individuals 
at increased risk for cognitive impairment and 
dementia in later life. 
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Context 
• Previous investigations have been cross-sectional; 
primarily use “first-generation” clocks to estimate 
epigenetic age; and test a limited number of cognitive 
abilities. 
• This study will use both first- and second-generation 
clocks to estimate epigenetic age and its effects on a 
range of cognitive functions in a longitudinal sample of 
middle-age adults. 
Project Deliverables
• By the end of the 1-year funding period, this 
pilot study will provide needed preliminary 
data for external NIH application, and will 
establish feasibility and key infrastructure for 
epigenetic age assays and calculation. 
• Within 1-2 years after funding period has 
ended, pilot data will be used in future 
applications that investigate longitudinal links 
between accelerated biological aging and 
cognitive aging among midlife adults in the 
larger AHAB cohort.
Motivation
• People can be biologically older or younger than their 
chronological age (Fig 1), and this difference may 
predict important health outcomes, including 
cognition. 
• Epigenetic biomarkers can be used to quantify 
biological age. 
Fig 1: Biological vs. Chronological Age
Dots below the red line 
represent a person biologically 
younger than their 
chronological age. 
Dots above the red line 
represent a person 
biologically older than 
their chronological 
age. 
